SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Harding Loevner International Equity Portfolio (HLMNX) trades at a trailing P/E of 39.9. Trailing earnings yield is 2.51%. PEG 0.21 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 0.21 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.51% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 71/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HLMNX
Valuation Multiples
P/E (TTM)39.9
Forward P/EN/A
PEG Ratio0.21
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.75
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.51%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-0.22 |
$861.86M |
$-27.09M |
-3.1% |
| 2015 |
$0.56 |
$714.89M |
$71.93M |
10.1% |
| 2016 |
$1.62 |
$500.68M |
$205.33M |
41% |
| 2017 |
$0.17 |
$340.57M |
$21.67M |
6.4% |
| 2018 |
$2.15 |
$197.02M |
$264.83M |
134.4% |
| 2019 |
$3.84 |
$127.85M |
$484.69M |
379.1% |
| 2020 |
$3.50 |
$66.28M |
$443.31M |
668.9% |
| 2021 |
$-0.20 |
$58M |
$-24.38M |
-42% |
| 2022 |
$0.26 |
$63.14M |
$29.28M |
46.4% |
| 2023 |
$0.75 |
$60.52M |
$83.18M |
137.4% |
